As adoption of molecular diagnostics for outpatient infections increases, several questions remain unanswered around the impact to patient outcomes and healthcare cost. Recent evidence suggests new PCR diagnostics can provide more accurate diagnoses and contribute to a reduction in follow-up outpatient healthcare services. Understand new molecular diagnostic technologies for infectious diseases, how to effectively implement a syndromic diagnostic approach and rapid results to improve patient care and reduce unnecessary follow-up costs.
Learning Objectives 1. Understand how targeted molecular diagnostic testing can be leveraged to inform accurate treatment decisions. 2. Workflow considerations when implementing molecular diagnostics to help reduce empiric prescribing. 3. Understand how effective implementation can contribute to reduced follow-up healthcare use and cost savings.
.png)
